NCT00945763View on ClinicalTrials.gov

Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Dental Pain
Interventions
DRUG

N1539

30 mg

DRUG

placebo

tablets

DRUG

N1539

15 mg

DRUG

N1539

60 mg

DRUG

Motrin

400 mg

Trial Locations (1)

84124

Jean Brown Research, Salt Lake City

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY